- Home
- EU vs EYPT Comparison
EU vs EYPT Comparison
Compare EU & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EU
- EYPT
- Stock Information
- Founded
- EU 2009
- EYPT 1987
- Country
- EU United States
- EYPT United States
- Employees
- EU N/A
- EYPT N/A
- Industry
- EU Other Metals and Minerals
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- EU Basic Materials
- EYPT Industrials
- Exchange
- EU Nasdaq
- EYPT Nasdaq
- Market Cap
- EU 445.3M
- EYPT 967.4M
- IPO Year
- EU N/A
- EYPT 2005
- Fundamental
- Price
- EU $3.04
- EYPT $11.95
- Analyst Decision
- EU Strong Buy
- EYPT Strong Buy
- Analyst Count
- EU 1
- EYPT 5
- Target Price
- EU $4.00
- EYPT $27.40
- AVG Volume (30 Days)
- EU 5.5M
- EYPT 1.5M
- Earning Date
- EU 11-13-2025
- EYPT 10-31-2025
- Dividend Yield
- EU N/A
- EYPT N/A
- EPS Growth
- EU N/A
- EYPT N/A
- EPS
- EU N/A
- EYPT N/A
- Revenue
- EU $44,524,000.00
- EYPT $51,898,000.00
- Revenue This Year
- EU $26.12
- EYPT N/A
- Revenue Next Year
- EU $103.15
- EYPT N/A
- P/E Ratio
- EU N/A
- EYPT N/A
- Revenue Growth
- EU 7.99
- EYPT 2.99
- 52 Week Low
- EU $1.01
- EYPT $3.91
- 52 Week High
- EU $4.19
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- EU 47.44
- EYPT 43.03
- Support Level
- EU $2.72
- EYPT $11.15
- Resistance Level
- EU $3.07
- EYPT $12.21
- Average True Range (ATR)
- EU 0.30
- EYPT 0.80
- MACD
- EU -0.10
- EYPT -0.22
- Stochastic Oscillator
- EU 22.18
- EYPT 21.68
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.